KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Net Margin (2016 - 2025)

Historic Net Margin for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to 8.84%.

  • BeOne Medicines' Net Margin rose 209600.0% to 8.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.38%, marking a year-over-year increase of 273200.0%. This contributed to the annual value of 16.92% for FY2024, which is 189400.0% up from last year.
  • Per BeOne Medicines' latest filing, its Net Margin stood at 8.84% for Q3 2025, which was up 209600.0% from 7.17% recorded in Q2 2025.
  • BeOne Medicines' 5-year Net Margin high stood at 27.57% for Q3 2023, and its period low was 320.24% during Q2 2021.
  • Its 5-year average for Net Margin is 83.9%, with a median of 57.94% in 2023.
  • Per our database at Business Quant, BeOne Medicines' Net Margin skyrocketed by 7405000bps in 2021 and then tumbled by -1529100bps in 2022.
  • BeOne Medicines' Net Margin (Quarter) stood at 276.04% in 2021, then soared by 58bps to 117.16% in 2022, then skyrocketed by 51bps to 57.94% in 2023, then soared by 77bps to 13.47% in 2024, then surged by 166bps to 8.84% in 2025.
  • Its Net Margin was 8.84% in Q3 2025, compared to 7.17% in Q2 2025 and 0.11% in Q1 2025.